Mind Medicine MindMed (MNMD)
(Delayed Data from NSDQ)
$9.64 USD
+0.28 (2.99%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $9.64 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Mind Medicine (MindMed) Inc. has a market cap of $728.33M, which represents its share price of $9.64 multiplied by its outstanding shares number of 75.55M. As a small-cap company, MNMD's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MNMD 9.64 +0.28(2.99%)
Will MNMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MNMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MNMD
Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?
All You Need to Know About Mind Medicine MindMed (MNMD) Rating Upgrade to Buy
MNMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Believe Mind Medicine MindMed (MNMD) Could Rally 237.47%: Here's is How to Trade
Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect?
MindMed Stock Skyrockets 94% Year to Date: What's Driving It?
Other News for MNMD
Oppenheimer Reinstates Mind Medicine (MNMD) with Outperform Rating | MNMD Stock News
Mind Medicine (MNMD) Gains Positive Outlook with Oppenheimer's Outperform Rating
Mind Medicine resumed with an Outperform at Oppenheimer
Mind Medicine (MNMD) Upgraded by Oppenheimer with Promising MM120 Outlook
Mind Medicine upgraded at Oppenheimer on lead asset